Marlowe plc (AIM:MRL) acquired entered into a binding agreement to acquire Optima Health Group Limited from CBPE Fund VIII LP, managed by CBPE Capital LLP and others for approximately £140 million on January 20, 2022. The Marlowe Group is launching a placing to raise £130 million to fund the acquisition. The acquisition consideration of £135 million, of which £6 million is proposed to be re-invested by Optima senior management into a future Group occupational health business incentive scheme, is payable in cash on completion and shall be funded from the net proceeds of the Placing and the Group's existing cash resources. As of September 30, 2021, on a last twelve month basis, Optima generated revenues of £66.3 million and adjusted EBITDA of £9.4 million and had net assets of £22.0 million, excluding private equity loan notes. The acquisition is conditional on, inter alia, admission of the placing shares to trading on AIM. The Marlowe Board expects the acquisition to be 10%+ accretive to Marlowe's adjusted earnings per share in the first 12 months post-completion. Nicholas Wells, Ben Jeynes and George Lawson of Cenkos Securities plc (AIM:CNKS) acted as financial advisors to Marlowe.

Marlowe plc (AIM:MRL) completed the acquisitions of Optima Health Group Limited from CBPE Fund VIII LP, managed by CBPE Capital LLP and others for approximately £140 million on January 20, 2022.